Terazosin 2mg tablets

দেশ: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)

সক্রিয় উপাদান:

Terazosin hydrochloride

থেকে পাওয়া:

Accord-UK Ltd

এটিসি কোড:

G04CA03

INN (আন্তর্জাতিক নাম):

Terazosin hydrochloride

ডোজ:

2mg

ফার্মাসিউটিকাল ফর্ম:

Oral tablet

প্রশাসন রুট:

Oral

শ্রেণী:

No Controlled Drug Status

প্রেসক্রিপশন টাইপ:

Valid as a prescribable product

পণ্য সারাংশ:

BNF: 02050400; GTIN: 5060149314128

তথ্য লিফলেট

PACKAGE LEAFLET: INFORMATION FOR THE
USER
TERAZOSIN 2 MG
TABLETS
TERAZOSIN 5 MG
TABLETS
Terazosin
Read all of this leaflet carefully before you start
taking this medicine because it contains
important information for you.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your
doctor or pharmacist.
•
This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them,
even if their signs of illness are the same as
yours.
•
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Terazosin Tablets are and what they are
used for
2. What you need to know before you take
Terazosin Tablets
3. How to take Terazosin Tablets
4. Possible side effects
5. How to store Terazosin Tablets
6. Contents of the pack and other information 1. WHAT TERAZOSIN TABLETS ARE
AND WHAT THEY ARE USED FOR
Terazosin belongs to the class of drugs known as
alpha-1- selective adrenoreceptor blocking
agents.
TERAZOSIN TABLETS ARE USED TO:
•
treat patients suffering from high blood
pressure. They help reduce blood pressure.
•
treat a condition called benign prostatic
hyperplasia which is common in older men. This
condition is caused by the prostate gland
growing too big and obstructing, it can partially
block the flow of urine from the bladder. This
leads to some unpleasant symptoms such as:
-
a weak or interrupted urine flow
-
a need to pass water more frequently and/or a
sudden need to pass water.
Terazosin can relax the muscle of the prostate
gland and bladder exit to help relieve these
symptoms.
Ask your doctor or pharmacist if you need
additional information. 2. WHAT YOU NEED TO KNOW BEFORE
YOU TAKE TERAZOSIN TABLETS
DO NOT TAKE TERAZOSIN TABLETS:
•
If you are allergic to active substance or any of
the other ingredients of this medicine (listed in
section 6).
•
If you have ever experienced a brief loss of
consciousness when passing water, o

পণ্য বৈশিষ্ট্য

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Terazosin 2 mg Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each
tablet contains 2 mg terazosin (as terazosin monohydrochloride
dihydrate).
Excipient with known effect:
Each tablet contains 119.93 mg of lactose (as lactose
monohydrate).
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Tablet.
Yellow coloured, round flat, tablets with bevelled edges and score
line on one
side of the tablet.
THIS TABLET CAN BE DIVIDED IN TO EQUAL HALVES
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Terazosin tablets are indicated for:
•
The treatment of mild to moderate hypertension
•
The symptomatic treatment of urinary obstruction caused by benign
prostatic
hyperplasia (BPH).
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
For oral use.
For the different dosage regimens suitable strengths are available.
The dose of terazosin should be adjusted according to the patient's
response.
The following is a guide to administration:
Initial dose
The lowest single dose of 1 mg before bedtime for all patients, which
should
not be exceeded. Strict compliance with this recommendation should be
observed to minimise potential acute first-dose hypotensive episodes.
SUBSEQUENT DOSES
Treatment of mild to moderate hypertension:
The single daily dosage may be increased by approximately doubling the
dosage at weekly intervals to achieve the desired blood pressure
response.
The maintenance dose needs to be adjusted to the patient’s response.
2 mg/day
may be sufficient with increases up to 10 mg if necessary (clinical
studies
support the use of 2 – 10 mg as maintenance dose).
The maximum dose is 20 mg of terazosin per day and should not be
exceeded.
Use with thiazide diuretics and other antihypertensive agents in the
treatment
of hypertension:
When
adding
a
thiazide
diuretic
or
another
antihypertensive
agent
to
a
patient's regimen the dose of terazosin should be reduced or
discontinued and
retitration carried out if necessary. Caution should